Suchergebnisse - "Drug Therapy, Combination"

PubPharm (710)

41

Identification of taste changes and nutritional implications in cancer patients : Identification of taste changes and nutritional implications in cancer patients

enthalten in: WHO International Clinical Trials Registry Platform | 2023

42

Identification of taste changes and nutritional implications in cancer patients : Identification of taste changes and nutritional implications in cancer patients

enthalten in: WHO International Clinical Trials Registry Platform | 2023

43

Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses

enthalten in: Journal for immunotherapy of cancer | 2023

von Kumar, A. | Ramani, V. | Bharti, V. | +8

ErratumIn: J Immunother Cancer. 2023 Jun;11(6):. - PMID 37344103

44

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

enthalten in: Journal for immunotherapy of cancer | 2023

von Strauss, J. | Deville, J. | Sznol, M. | +16

45

„Polypill“ in der kardiovaskulären Prävention – erfolgreich durch Vereinfachung?

enthalten in: Die Innere Medizin | 2023

von Despang, P. | Schikora, M. | Doehner, W.

46

„Polypill“ in der kardiovaskulären Prävention – erfolgreich durch Vereinfachung?

enthalten in: Die innere Medizin | 2023

von Despang, P. | Schikora, M. | Doehner, W.

47

„Polypill“ in der kardiovaskulären Prävention – erfolgreich durch Vereinfachung?

enthalten in: Der Internist | 2023

von Despang, P. | Schikora, M. | Doehner, W.

48

Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment

enthalten in: Journal for immunotherapy of cancer | 2023

von Xu, P. | Yang, J. | Chen, B. | +7

49

Combination Therapies for Advanced Biliary Tract Cancer

enthalten in: Journal of clinical and translational hepatology | 2023

von Zeng, W. | Mao, R. | Zhang, Z. | +1

50

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors

enthalten in: Journal for immunotherapy of cancer | 2023

von Fu, Y. | Yang, B. | Cui, Y. | +18